Microbiology Devices; Reclassification of Mycobacterium Tuberculosis Cell-Mediated Immunity Tests and Immune Response Enzyme-Linked Immunospot Tests

NonrulemakingProposed RuleFDA-2026-N-2590-0001
🔔 Subscribe
Document

Details

The document's own metadata, straight from regulations.gov.

Posted
Mar 30, 2026
Agency
Food and Drug Administration (FDA)
© 2026 Government Context · not affiliated with any U.S. government agencyPrivacyTermsDockets